Literature DB >> 19898961

Comparison of beta-catenin with TGF-beta1, HIF-1alpha and patients' disease-free survival in human colorectal cancer.

Andrzej Wincewicz1, Mariusz Koda, Stanislaw Sulkowski, Luiza Kanczuga-Koda, Mariola Sulkowska.   

Abstract

Beta-catenin accumulation is suppressed by TGF-beta1 (transforming growth factor beta1) in intestinal epithelium suggesting negative feedback between these two factors. Besides that, beta-catenin interacts with HIF-1alpha (hypoxia-inducible factor-1alpha) at the promoter region of HIF-1 target genes. Our study was aimed at comparison of beta-catenin with HIF-1alpha, TGF-beta1, Ki67 and survival of sporadic colorectal cancer patients. Expressions of beta-catenin, TGF-beta1, HIF-1alpha, Ki67 were evaluated in triads of specimens of each primary tumor of 72 sporadic colorectal cancers with immunohistochemistry due to limited availability of tissue material. Disease-free survival was analyzed in case of all 100 beta-catenin stained tumors, in 85 cancers stained for HIF-1 and in 72 neoplasms with TGFbeta1 staining. Beta-catenin, TGF-beta1 and HIF-1alpha accumulated in 72 colorectal cancer cells. Beta-catenin correlated both with HIF-1alpha and TGF-beta1 in all colorectal cancers (p < 0.009, r = 0.307 and p = 0.003, r = 0.342, respectively) and in subgroups of different clinico-pathological profile. Beta-catenin failed to correlate with Ki67. In case of beta-catenin, TGF-beta1 and HIF-1alpha, disease-free survival curves failed to show any statistically significant differences between groups of marker negative tumors, cancers with low expression and neoplasms with higher protein expression. Positive correlations between beta-catenin and TGF-beta1 may indicate ineffective attempts of TGF-beta1 to reduce intracellular level of beta-catenin in colorectal cancer. Associations between beta-catenin and HIF-1alpha reflect previously detected interactions between HIF-1alpha with beta-catenin and are confirmative for presence of such reactions in human colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19898961     DOI: 10.1007/s12253-009-9217-2

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  30 in total

1.  Expression of tight and adherens junction proteins in ulcerative colitis associated colorectal carcinoma: upregulation of claudin-1, claudin-3, claudin-4, and beta-catenin.

Authors:  S T Mees; R Mennigen; T Spieker; E Rijcken; N Senninger; J Haier; M Bruewer
Journal:  Int J Colorectal Dis       Date:  2009-01-29       Impact factor: 2.571

2.  TGF-beta signaling in colon cancer cells.

Authors:  Fazhi Li; Yanna Cao; Courtney M Townsend; Tien C Ko
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

3.  Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.

Authors:  J Xu; L Attisano
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

4.  Relations of TGF-beta1 with HIF-1 alpha, GLUT-1 and longer survival of colorectal cancer patients.

Authors:  Mariola Sulkowska; Andrzej Wincewicz; Stanislaw Sulkowski; Mariusz Koda; Luiza Kanczuga-Koda
Journal:  Pathology       Date:  2009       Impact factor: 5.306

5.  Intravasation-related metastatic factors in colorectal cancer.

Authors:  Yu-Wen Tien; Yung-Ming Jeng; Rey-Heng Hu; King-Jen Chang; Su-Ming Hsu; Po-Huang Lee
Journal:  Tumour Biol       Date:  2004 Jan-Apr

6.  CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer.

Authors:  David Horst; Lydia Kriegl; Jutta Engel; Andreas Jung; Thomas Kirchner
Journal:  Eur J Cancer       Date:  2009-05-04       Impact factor: 9.162

7.  Switch of transforming growth factor beta function from tumor suppression to stimulation in adenomatous polyposis coli (APC) knocked-down human colon carcinoma cells.

Authors:  Hongmei Wang; Moltira Promkan; Guangming Liu; Subhas Chakrabarty
Journal:  Cancer Lett       Date:  2008-09-06       Impact factor: 8.679

8.  TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.

Authors:  David Bacman; Susanne Merkel; Roland Croner; Thomas Papadopoulos; Wolfgang Brueckl; Arno Dimmler
Journal:  BMC Cancer       Date:  2007-08-10       Impact factor: 4.430

9.  The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.

Authors:  Marc de la Roche; Jesper Worm; Mariann Bienz
Journal:  BMC Cancer       Date:  2008-07-15       Impact factor: 4.430

10.  Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.

Authors:  Kayoko Takeda; Ichiro Kinoshita; Yasushi Shimizu; Yusuke Ohba; Tomoo Itoh; Yoshihiro Matsuno; Toshiaki Shichinohe; Hirotoshi Dosaka-Akita
Journal:  BMC Cancer       Date:  2008-11-08       Impact factor: 4.430

View more
  3 in total

1.  Hypoxia and cytokines regulate carbonic anhydrase 9 expression in hepatocellular carcinoma cells in vitro.

Authors:  Feray Kockar; Hatice Yildrim; Rahsan Ilikci Sagkan; Carsten Hagemann; Yasemin Soysal; Jelena Anacker; Ahmed Ayad Hamza; Dirk Vordermark; Michael Flentje; Harun M Said
Journal:  World J Clin Oncol       Date:  2012-06-10

2.  Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis.

Authors:  Xin-Lin Chen; Zhuo-Qun Chen; Shui-Lian Zhu; Tian-Wen Liu; Yi Wen; Yi-Sheng Su; Xu-Jie Xi; Yue Hu; Lei Lian; Feng-Bin Liu
Journal:  BMC Cancer       Date:  2017-04-04       Impact factor: 4.430

3.  Hypoxia triggers a Nur77-β-catenin feed-forward loop to promote the invasive growth of colon cancer cells.

Authors:  S K Y To; W-J Zeng; J-Z Zeng; A S T Wong
Journal:  Br J Cancer       Date:  2014-01-14       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.